Ost-müük Jaguar Health, Inc. - JAGX CFD
Lisa lemmikuks- Kokkuvõte
- Ajaloolised andmed
- Sündmused
- Tuluaruanne
- Bilanss
- Rahavood
- Omand
Kauplemistingimused
| Hinnavahe | - | ||||||||
|
Pika positsiooni ööpäeva tasu
Long position overnight fee
Mine platvormile | -0.024068% | ||||||||
|
Lühikese positsiooni ööpäeva tasu
Short position overnight fee
Mine platvormile | 0.001846% | ||||||||
| Ööpäeva tasu aeg | 21:00 (UTC) | ||||||||
| Min kauplemise kogus | 1 | ||||||||
| Valuuta | USD | ||||||||
| Tagatis | 20% | ||||||||
| Aktsiabörs | United States of America | ||||||||
| Kauplemise vahendustasu | 0% |
*Information provided by Capital.com
Võtmestatistika
| Eelmine sulgemine* | N/A |
| Avatud* | N/A |
| Aastane muutus* | N/A |
| Päeva ulatus* | N/A |
| 52 nädala ulatus | 0.73-61.13 |
| Keskmine maht (10 päeva) | 3.05M |
| Keskmine maht (3 kuud) | 19.28M |
| Turukapitalisatsioon | 1.96M |
| P/E suhtarv | -100.00K |
| Ringluses olevad aktsiad | 4.03M |
| Tulu | 10.78M |
| EPS | -58.95 |
| Dividendid (% kasumist) | N/A |
| Beeta | 1.93 |
| Järgmine tuluaruande kuupäev | Mar 24, 2023 |
Kõigi andmete allikas on Refinitiv, välja arvatud tärniga märgitud, kus *-ga andmed on esitanud Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Sulgemishind | Change (%) | Avamishind | High | Low |
|---|
Jaguar Health, Inc. Events
| Kellaaeg (UTC) (UTC) | Riik | Sündmus |
|---|---|---|
| No events scheduled | ||
- Aastas
- Kvartalis
| 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|
| Kogutulu | 4.335 | 9.385 | 5.77526 | 4.41615 | 4.36119 |
| Tulu | 4.335 | 9.385 | 5.77526 | 4.41615 | 4.36119 |
| Kulud, Kokku | 2.333 | 3.28 | 3.81581 | 2.76575 | 0.88041 |
| Brutokasum | 2.002 | 6.105 | 1.95945 | 1.6504 | 3.48078 |
| Kogu tegevuskulu | 45.796 | 37.896 | 39.6643 | 34.5802 | 39.0853 |
| Müük/Üldine/admin kulud, kokku | 25.997 | 20.996 | 20.4389 | 22.1088 | 14.3314 |
| Uuringud ja arendus | 15.079 | 6.413 | 5.81982 | 5.15475 | 4.26946 |
| Ootamatud kulutused (tulu) | 2.387 | 7.207 | 9.58971 | 4.55093 | 19.604 |
| Tulud majandustegevusest | -41.461 | -28.511 | -33.889 | -30.1641 | -34.7241 |
| Intressitulud (kulu), muud tulud, neto | -10.374 | -5.488 | -4.72125 | -2.29767 | -0.51429 |
| Muud, neto | -0.765 | 0.19 | 0.08083 | 0.31569 | 0.08855 |
| Netotulu enne makse | -52.6 | -33.809 | -38.5294 | -32.1461 | -35.1499 |
| Netotulu pärast makse | -52.6 | -33.809 | -38.5394 | -32.1461 | -21.9686 |
| Netotulu enne erikulusid | -52.595 | -33.809 | -38.5394 | -32.1461 | -21.9686 |
| Netotulu | -52.595 | -33.809 | -38.5394 | -32.1461 | -21.9686 |
| Total Adjustments to Net Income | 0 | -4.839 | -6.18681 | ||
| Arvestatav tulu, v a erikulud | -52.595 | -38.648 | -44.7262 | -32.1461 | -21.9686 |
| Arvestatav tulu, koos erikuludega | -52.595 | -38.648 | -44.7262 | -32.1461 | -21.9686 |
| Jaotamisele kuuluv netotulu | -52.595 | -38.648 | -44.7262 | -32.1461 | -21.9686 |
| Keskmine jaotamisele kuuluv aktsia kohta | 44.7116 | 12.8807 | 1.6551 | 0.06991 | 0.96523 |
| Jaotatav EPS, v a erakorralised kulud | -1.17632 | -3.00045 | -27.0234 | -459.827 | -22.7599 |
| Dividends per Share - Common Stock Primary Issue | |||||
| Jaotamisele kuuluv normaal-EPS | -1.12293 | -2.44093 | -23.2572 | -394.729 | -9.55829 |
| Erakorralised kulud kokku | 0 | ||||
| Vähemuse intress | 0.005 |
| Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
|---|---|---|---|---|---|
| Kogutulu | 2.625 | 2.08 | 0.63 | 0.385 | 1.241 |
| Tulu | 2.625 | 2.08 | 0.63 | 0.385 | 1.241 |
| Kulud, Kokku | 0.455 | 0.469 | 0.617 | 0.664 | 0.583 |
| Brutokasum | 2.17 | 1.611 | 0.013 | -0.279 | 0.658 |
| Kogu tegevuskulu | 17.194 | 12.902 | 10.159 | 11.965 | 10.76 |
| Müük/Üldine/admin kulud, kokku | 8.979 | 6.951 | 6.23 | 7.259 | 5.548 |
| Uuringud ja arendus | 4.945 | 5.482 | 3.312 | 3.87 | 2.414 |
| Ootamatud kulutused (tulu) | 2.815 | 0 | 0 | 0.172 | 2.215 |
| Tulud majandustegevusest | -14.569 | -10.822 | -9.529 | -11.58 | -9.519 |
| Intressitulud (kulu), muud tulud, neto | -4.427 | -2.747 | -2.643 | -2.484 | -2.5 |
| Muud, neto | 0.832 | -0.749 | -0.02 | -0.017 | 0.01 |
| Netotulu enne makse | -18.164 | -14.318 | -12.192 | -14.081 | -12.009 |
| Netotulu pärast makse | -18.164 | -14.318 | -12.192 | -14.081 | -12.009 |
| Netotulu enne erikulusid | -17.986 | -14.313 | -12.192 | -14.081 | -12.009 |
| Netotulu | -17.986 | -14.313 | -12.192 | -14.081 | -12.009 |
| Total Adjustments to Net Income | 0 | 0 | 0 | 0 | |
| Arvestatav tulu, v a erikulud | -17.986 | -14.313 | -12.192 | -14.081 | -12.009 |
| Arvestatav tulu, koos erikuludega | -17.986 | -14.313 | -12.192 | -14.081 | -12.009 |
| Jaotamisele kuuluv netotulu | -17.986 | -14.313 | -12.192 | -14.081 | -12.009 |
| Keskmine jaotamisele kuuluv aktsia kohta | 44.7116 | 46.3427 | 45.8403 | 44.8117 | 41.805 |
| Jaotatav EPS, v a erakorralised kulud | -0.40227 | -0.30885 | -0.26597 | -0.31423 | -0.28726 |
| Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
| Jaotamisele kuuluv normaal-EPS | -0.33931 | -0.30885 | -0.26597 | -0.31039 | -0.23428 |
| Vähemuse intress | 0.178 | 0.005 |
- Aastas
- Kvartalis
| 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|
| Käibevarad kokku | 28.434 | 17.792 | 9.52235 | 8.14994 | 3.7991 |
| Raha ja lühiajalised investeeringud | 17.051 | 8.09 | 3.49543 | 2.56819 | 0.5207 |
| Raha ja ekvivalendid | 0.5207 | ||||
| Laekumata arved, neto | 2.144 | 4.56 | 1.69458 | 1.0018 | 0.46904 |
| Accounts Receivable - Trade, Net | 1.709 | 4.532 | 1.69171 | 0.99568 | 0.46766 |
| Total Inventory | 4.9 | 2.782 | 2.12869 | 3.34218 | 2.07282 |
| Prepaid Expenses | 4.339 | 2.36 | 1.26274 | 1.23777 | 0.49737 |
| Other Current Assets, Total | 0 | 0.94091 | 0 | 0.23917 | |
| Total Assets | 53.265 | 42.843 | 36.4104 | 41.042 | 43.6292 |
| Property/Plant/Equipment, Total - Net | 1.734 | 0.677 | 0.71021 | 0.76062 | 1.22207 |
| Other Long Term Assets, Total | 0.446 | 0.037 | 0.15397 | 0.42083 | 0 |
| Total Current Liabilities | 15.471 | 13.22 | 15.3924 | 26.6588 | 15.3858 |
| Accounts Payable | 4.929 | 4.759 | 5.35154 | 5.41426 | 7.35493 |
| Accrued Expenses | 7.357 | 4.493 | 3.2589 | 4.93944 | 2.19955 |
| Notes Payable/Short Term Debt | 0 | 0 | 0 | 4.84558 | 1.14115 |
| Current Port. of LT Debt/Capital Leases | 3.184 | 3.789 | 6.77846 | 11.2392 | 4.28146 |
| Other Current Liabilities, Total | 0.001 | 0.179 | 0.00349 | 0.22038 | 0.40867 |
| Total Liabilities | 41.654 | 25.641 | 15.8424 | 26.6588 | 26.3682 |
| Total Long Term Debt | 25.022 | 12.421 | 0.45 | 0 | 10.9824 |
| Long Term Debt | 25.022 | 12.421 | 0.45 | 0 | 10.9824 |
| Other Liabilities, Total | 0.919 | 0 | |||
| Total Equity | 11.611 | 17.202 | 20.568 | 14.3831 | 17.261 |
| Redeemable Preferred Stock | 0 | 0 | 11.6065 | 9 | 0 |
| Common Stock | 0.005 | 0.011 | 0.00546 | 0.00649 | 0.01053 |
| Additional Paid-In Capital | 231.1 | 184.09 | 142.046 | 99.9274 | 79.6552 |
| Retained Earnings (Accumulated Deficit) | -219.494 | -166.899 | -133.09 | -94.5508 | -62.4047 |
| Total Liabilities & Shareholders’ Equity | 53.265 | 42.843 | 36.4104 | 41.042 | 43.6292 |
| Total Common Shares Outstanding | 50.4733 | 40.1279 | 45.0589 | 40.4184 | 42.6378 |
| Goodwill, Net | 0 | 5.21082 | |||
| Intangibles, Net | 22.651 | 24.337 | 26.0239 | 31.7106 | 33.3972 |
| Cash | 17.051 | 8.09 | 3.49543 | 2.56819 | |
| Property/Plant/Equipment, Total - Gross | 2.032 | 0.942 | 0.93428 | ||
| Accumulated Depreciation, Total | -0.298 | -0.265 | -0.22407 | ||
| Total Preferred Shares Outstanding | 0 | 0 | 5.53706 | ||
| Minority Interest | 0.242 |
| Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
|---|---|---|---|---|---|
| Käibevarad kokku | 28.474 | 28.434 | 24.005 | 44.294 | 44.104 |
| Raha ja lühiajalised investeeringud | 17.456 | 17.051 | 12.375 | 21.992 | 32.25 |
| Cash | 17.456 | 17.051 | 12.375 | 21.992 | 32.25 |
| Laekumata arved, neto | 2.255 | 2.144 | 2.205 | 4.174 | 5.927 |
| Accounts Receivable - Trade, Net | 1.795 | 1.709 | 2.111 | 4.134 | 5.897 |
| Total Inventory | 4.879 | 4.9 | 4.513 | 3.402 | 2.821 |
| Prepaid Expenses | 3.884 | 4.339 | 4.912 | 4.806 | 3.106 |
| Other Current Assets, Total | 9.92 | 0 | |||
| Total Assets | 52.906 | 53.265 | 59.255 | 69.539 | 68.713 |
| Property/Plant/Equipment, Total - Net | 1.757 | 1.734 | 1.7 | 1.751 | 0.674 |
| Property/Plant/Equipment, Total - Gross | 2.18 | 2.032 | 1.99 | 2.033 | 0.948 |
| Accumulated Depreciation, Total | -0.423 | -0.298 | -0.29 | -0.282 | -0.274 |
| Intangibles, Net | 22.229 | 22.651 | 23.072 | 23.494 | 23.916 |
| Other Long Term Assets, Total | 0.446 | 0.446 | 10.478 | 0 | 0.019 |
| Total Current Liabilities | 19.093 | 15.471 | 11.951 | 12.652 | 12.592 |
| Accounts Payable | 3.708 | 4.929 | 3.786 | 4.918 | 4.74 |
| Accrued Expenses | 8.494 | 7.357 | 6.381 | 6.582 | 6.409 |
| Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
| Current Port. of LT Debt/Capital Leases | 6.89 | 3.184 | 1.781 | 1.145 | 1.431 |
| Other Current Liabilities, Total | 0.001 | 0.001 | 0.003 | 0.007 | 0.012 |
| Total Liabilities | 44.861 | 41.654 | 37.703 | 37.754 | 36.822 |
| Total Long Term Debt | 24.783 | 25.022 | 24.926 | 24.195 | 24.23 |
| Long Term Debt | 24.783 | 25.022 | 24.926 | 24.195 | 24.23 |
| Total Equity | 8.045 | 11.611 | 21.552 | 31.785 | 31.891 |
| Redeemable Preferred Stock | 0 | 0 | 0 | 0 | 0 |
| Common Stock | 0.008 | 0.005 | 0.005 | 0.014 | 0.013 |
| Additional Paid-In Capital | 245.517 | 231.1 | 226.728 | 224.76 | 210.786 |
| Retained Earnings (Accumulated Deficit) | -237.48 | -219.494 | -205.181 | -192.989 | -178.908 |
| Total Liabilities & Shareholders’ Equity | 52.906 | 53.265 | 59.255 | 69.539 | 68.713 |
| Total Common Shares Outstanding | 79.1948 | 50.4733 | 48.2117 | 47.8944 | 44.7563 |
| Total Preferred Shares Outstanding | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities, Total | 0.921 | 0.919 | 0.826 | 0.907 | |
| Minority Interest | 0.064 | 0.242 |
- Aastas
- Kvartalis
| 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|
| Netotulu/algväärtus | -52.6 | -33.809 | -38.5394 | -32.1461 | -21.9686 |
| Raha majandustegevusest | -34.97 | -15.278 | -20.4568 | -22.7308 | -9.82494 |
| Raha majandustegevusest | 1.719 | 1.727 | 1.73708 | 1.319 | 0.58434 |
| Mittelikviidsed varad | 13.644 | 20.271 | 17.0073 | 9.02132 | 20.6123 |
| Makstud intressid | 0.028 | 0.757 | 0.142 | 0.01934 | 0.23455 |
| Muutused tööjõus | 2.267 | -3.467 | -0.66177 | -0.9251 | 4.12831 |
| Tulu investeeringutelt | -0.006 | -0.007 | 0 | -0.00653 | -1.55734 |
| Kapitalikulutused | -0.006 | -0.007 | -0.00653 | 0 | |
| Muud rahavood investeeringutelt, kokku | 0 | 0 | -1.55734 | ||
| Rahavood investeeringutelt | 43.937 | 19.492 | 21.772 | 24.5457 | 10.6799 |
| Rahavoogudesse investeerimine | -0.731 | -1.008 | -2.57481 | -2.11755 | 0 |
| Aktsiate emiteerimine (tagasiost), neto | 35.615 | 7.756 | 24.4468 | 25.8797 | 10.302 |
| Laenu väljastamine (kustutamine), neto | 9.053 | 12.744 | -0.1 | 0.78349 | 0.37791 |
| Rahaline kogumuutus | 8.961 | 4.207 | 1.31519 | 1.80832 | -0.70241 |
| Deferred Taxes | 0 | -13.1812 |
| Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
|---|---|---|---|---|---|
| Net income/Starting Line | -18.164 | -52.6 | -38.282 | -26.09 | -12.009 |
| Cash From Operating Activities | -7.695 | -34.97 | -26.047 | -16.615 | -6.708 |
| Cash From Operating Activities | 0.426 | 1.719 | 1.29 | 0.861 | 0.431 |
| Non-Cash Items | 7.583 | 13.644 | 10.601 | 7.609 | 4.695 |
| Cash Interest Paid | 0.011 | 0.028 | 0.021 | 0.008 | 0.006 |
| Changes in Working Capital | 2.46 | 2.267 | 0.344 | 1.005 | 0.175 |
| Cash From Investing Activities | -0.006 | -10.484 | -0.006 | 0 | |
| Capital Expenditures | -0.006 | -0.006 | -0.006 | 0 | |
| Cash From Financing Activities | 8.15 | 43.937 | 40.816 | 40.443 | 30.868 |
| Financing Cash Flow Items | -0.335 | -0.731 | -0.623 | -0.268 | -0.095 |
| Issuance (Retirement) of Stock, Net | 9.11 | 35.615 | 32.386 | 31.608 | 21.86 |
| Issuance (Retirement) of Debt, Net | -0.625 | 9.053 | 9.053 | 9.103 | 9.103 |
| Net Change in Cash | 0.405 | 8.961 | 4.285 | 23.822 | 24.16 |
| Other Investing Cash Flow Items, Total | -10.478 | ||||
| Foreign Exchange Effects | -0.05 |
Miks valida Capital.com? Meie numbrid räägivad iseenda eest.
Capital.com Group500K+
Kauplejad
92K+
Igakuiste aktiivsete klientide arv
$53M+
Igakuine investeerimise maht
$30M+
Igakuiselt välja võetud
Kauplemiskalkulaator
Arvutage oma hüpoteetiline võit/kaotus, kui oleksite avanud CFD-tehingu ühel kindlal kuupäeval (valige kuupäev) ja sulgenud teisel kuupäeval (valige kuupäev).
Kauplemise vahendustasu
0
- 1:1
Finantsvõimendus
1:1
- 20
- 100
- 500
- 1000
- 10000
Investeering
Tehingu suurus (võimendus x investeering):
Avamishind
Close
Lühike Pikk
Jaguar Health, Inc. Company profile
Ettevõttest Jaguar Health, Inc.
Jaguar Health, Inc. on kommertsjärgus farmaatsiaettevõte. Ettevõte keskendub taimepõhiste, opioidivabade ja jätkusuutlikult toodetud retseptiravimite väljatöötamisele inimestele ja loomadele, kellel on seedetrakti häired, sealhulgas krooniline ja invaliidistav kõhulahtisus. Ettevõte tegutseb kahes segmendis: inimeste tervis ja loomade tervis. Loomatervishoiu segment keskendub retsepti- ja käsimüügiravimite arendamisele ja turustamisele lemmik- ja produktiivloomadele. Canalevia-CA1 kasutatakse kemoteraapiast tingitud kõhulahtisuse korral koertel. Inimeste tervishoiusegment keskendub inimtervishoiutoodete väljatöötamisele ja turustamisele ning käimasolevale Mytesi turustamisele, mida kasutatakse mittenakkusliku kõhulahtisuse sümptomaatiliseks leevendamiseks inimese immuunpuudulikkuse viiruse (HIV) / omandatud immuunpuudulikkuse sündroomiga (AIDS) täiskasvanutel, kes saavad retroviirusevastast ravi. Ettevõtte 100-protsendiline tütarettevõte on Napo Pharmaceuticals, Inc.
| Industry: | Bio Therapeutic Drugs |
200 Pine Street Suite 400
SAN FRANCISCO
CALIFORNIA 94104
US
Tuluaruanne
- Annual
- Quarterly
Teised on vaadanud veel
Kas otsite jätkuvalt vahendajat, keda saab usaldada?
Ühinege 500,000+ kauplejaga üle kogu maailma, kes valisid kauplemiseks veebisaidi Capital.com